M. T. Andreoli, M. Pinnolis, T. Kieser, J. Sun, and C. M. Andreoli, “Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration”, Digit J Ophthalmol, vol. 21, no. 3, pp. 29–34, Sep. 2015.